Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.

Hodis HN, Mack WJ.

Brain Res. 2011 Mar 16;1379:244-52. doi: 10.1016/j.brainres.2010.10.076. Epub 2010 Oct 25. Review.

2.

Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention.

Franke AA, Hebshi SM, Pagano I, Kono N, Mack WJ, Hodis HN.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1775-83. doi: 10.1158/1055-9965.EPI-10-0116.

3.

Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials.

Taku K, Lin N, Cai D, Hu J, Zhao X, Zhang Y, Wang P, Melby MK, Hooper L, Kurzer MS, Mizuno S, Ishimi Y, Watanabe S.

J Hypertens. 2010 Oct;28(10):1971-82. doi: 10.1097/HJH.0b013e32833c6edb. Review.

PMID:
20577121
4.

Mechanisms of anti-atherosclerotic functions of soy-based diets.

Nagarajan S.

J Nutr Biochem. 2010 Apr;21(4):255-60. doi: 10.1016/j.jnutbio.2009.09.002. Epub 2009 Dec 1. Review.

PMID:
19954957
5.

Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG, Effron MB, Dowsett SA, Barrett-Connor E, Wenger NK.

Circulation. 2009 Feb 24;119(7):922-30. doi: 10.1161/CIRCULATIONAHA.108.817577. Epub 2009 Feb 9.

6.

Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice.

Averill MM, Bennett BJ, Rattazzi M, Rodmyre RM, Kirk EA, Schwartz SM, Rosenfeld ME.

Atherosclerosis. 2009 Mar;203(1):82-8. doi: 10.1016/j.atherosclerosis.2008.06.017. Epub 2008 Jul 1.

7.

Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women.

Rios DR, Rodrigues ET, Cardoso AP, Montes MB, Franceschini SA, Toloi MR.

Nutrition. 2008 Feb;24(2):120-6. Epub 2007 Dec 11.

PMID:
18065202
8.

Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I.

Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S; JPHC Study Group.

Circulation. 2007 Nov 27;116(22):2553-62. Epub 2007 Nov 19.

9.

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women.

Cassidy A, Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y, Wolk A, Steiner C, Branca F.

Proc Nutr Soc. 2006 Feb;65(1):76-92. Review.

PMID:
16441947
10.

Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.

Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M; American Heart Association Nutrition Committee.

Circulation. 2006 Feb 21;113(7):1034-44. Epub 2006 Jan 17.

11.

Soybean foods and their benefits: potential mechanisms of action.

Omoni AO, Aluko RE.

Nutr Rev. 2005 Aug;63(8):272-83. Review.

PMID:
16190314
12.

Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women.

Teede HJ, Dalais FS, Kotsopoulos D, McGrath BP, Malan E, Gan TE, Peverill RE.

J Clin Endocrinol Metab. 2005 Apr;90(4):1936-41. Epub 2005 Jan 18.

PMID:
15657372
13.

Soy food consumption is associated with lower risk of coronary heart disease in Chinese women.

Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F, Zheng W.

J Nutr. 2003 Sep;133(9):2874-8.

14.

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH; Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group.

N Engl J Med. 2003 Aug 7;349(6):535-45.

15.
16.

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E.

J Nutr. 2002 Dec;132(12):3577-84. Review.

17.

The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha.

Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N, Williams JK.

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1859-64.

18.

Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).

Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP; VEAPS Research Group.

Circulation. 2002 Sep 17;106(12):1453-9.

19.
20.

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP; Estrogen in the Prevention of Atherosclerosis Trial Research Group.

Ann Intern Med. 2001 Dec 4;135(11):939-53.

PMID:
11730394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk